Developing an antibody treatment that is effective against the omicron variant of COVID-19 has paying off for Eli Lilly. But the company may soon lose …

After the Supreme Court overturned the landmark Roe v. Wade ruling, companies across industries are stepping in to support employees who need to cross state …

With Congress weighing a cap on out-of-pocket costs for insulin for certain individuals, Sanofi has beaten the government to the punch. The Paris-based company says it will …

Johnson & Johnson is boosting its “Positively Fearless” HIV campaign as it looks to break the old stigma attached to the disease whilst boosting its …

Fujifilm isn’t slowing down on its expansion roll. Just a few months after it bought Shenandoah Biotechnology for an undisclosed sum, the Japanese conglomerate has unveiled …

For months, Novartis has hinted at layoffs coming for some of its global staff. Now, the news has come down from HQ. Novartis is laying …

It turns out that even more than the blinding pain, the nausea, the photosensitivity or crushing fatigue, the worst part of migraine is often the …

This spring, when the FDA pushed its target date for pediatric approval of Merck’s pneumococcal vaccine Vaxneuvance back by 90 days, it was a blow …

As authorities continue to probe irregularities in the HIV drug supply chain, a Florida man has been arrested for his alleged role in a nationwide scheme to …

Bristol Myers Squibb, Pfizer and Merck will face extreme patent cliff exposure later in this decade. But those companies also have the financial flexibility to …